JPS61177999A - β−Ｎ−アセチル−Ｄ−ヘキソサミニダ−ゼ活性測定試薬 - Google Patents
β−Ｎ−アセチル−Ｄ−ヘキソサミニダ−ゼ活性測定試薬Info
- Publication number
- JPS61177999A JPS61177999A JP1745285A JP1745285A JPS61177999A JP S61177999 A JPS61177999 A JP S61177999A JP 1745285 A JP1745285 A JP 1745285A JP 1745285 A JP1745285 A JP 1745285A JP S61177999 A JPS61177999 A JP S61177999A
- Authority
- JP
- Japan
- Prior art keywords
- reagent
- acetyl
- substrate
- nitro
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 19
- 230000000694 effects Effects 0.000 title claims description 18
- 102000007478 beta-N-Acetylhexosaminidases Human genes 0.000 title claims description 8
- 108010085377 beta-N-Acetylhexosaminidases Proteins 0.000 title claims description 8
- 239000000758 substrate Substances 0.000 claims abstract description 17
- 125000003118 aryl group Chemical group 0.000 claims abstract description 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 8
- 150000001875 compounds Chemical class 0.000 claims abstract description 7
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 5
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 238000010521 absorption reaction Methods 0.000 claims abstract description 4
- 239000011780 sodium chloride Substances 0.000 claims abstract description 4
- 125000001424 substituent group Chemical group 0.000 claims abstract description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 230000003595 spectral effect Effects 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 2
- 238000003556 assay Methods 0.000 abstract description 5
- 239000007853 buffer solution Substances 0.000 abstract description 4
- 229950006780 n-acetylglucosamine Drugs 0.000 abstract description 4
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 abstract description 3
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 abstract description 3
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 abstract description 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 abstract description 3
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 abstract description 3
- OVRNDRQMDRJTHS-CBQIKETKSA-N N-Acetyl-D-Galactosamine Chemical group CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O OVRNDRQMDRJTHS-CBQIKETKSA-N 0.000 abstract description 2
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 abstract description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 238000001228 spectrum Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 description 9
- 210000001124 body fluid Anatomy 0.000 description 4
- 239000010839 body fluid Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical group OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000007979 citrate buffer Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 208000009304 Acute Kidney Injury Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010018366 Glomerulonephritis acute Diseases 0.000 description 1
- OVRNDRQMDRJTHS-BKJPEWSUSA-N N-acetyl-D-hexosamine Chemical compound CC(=O)NC1C(O)O[C@H](CO)C(O)C1O OVRNDRQMDRJTHS-BKJPEWSUSA-N 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 208000033626 Renal failure acute Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 101100020289 Xenopus laevis koza gene Proteins 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000011040 acute kidney failure Diseases 0.000 description 1
- 208000012998 acute renal failure Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 230000000850 deacetylating effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 230000002140 halogenating effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1745285A JPS61177999A (ja) | 1985-01-30 | 1985-01-30 | β−Ｎ−アセチル−Ｄ−ヘキソサミニダ−ゼ活性測定試薬 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP1745285A JPS61177999A (ja) | 1985-01-30 | 1985-01-30 | β−Ｎ−アセチル−Ｄ−ヘキソサミニダ−ゼ活性測定試薬 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61177999A true JPS61177999A (ja) | 1986-08-09 |
| JPH0573398B2 JPH0573398B2 (enExample) | 1993-10-14 |
Family
ID=11944412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1745285A Granted JPS61177999A (ja) | 1985-01-30 | 1985-01-30 | β−Ｎ−アセチル−Ｄ−ヘキソサミニダ−ゼ活性測定試薬 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61177999A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990010084A1 (fr) * | 1989-02-23 | 1990-09-07 | Iatron Laboratories, Inc. | Substrat de determination d'activite enzymatique et procede et reactif de determination d'activite enzymatique utilisant ledit substrat |
-
1985
- 1985-01-30 JP JP1745285A patent/JPS61177999A/ja active Granted
Non-Patent Citations (2)
| Title |
|---|
| BIOCHEMICAL PLEPARATIONS=1963 * |
| METHODS ENZYMOL=1972 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990010084A1 (fr) * | 1989-02-23 | 1990-09-07 | Iatron Laboratories, Inc. | Substrat de determination d'activite enzymatique et procede et reactif de determination d'activite enzymatique utilisant ledit substrat |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0573398B2 (enExample) | 1993-10-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Fishman | β-Glucuronidase | |
| Farman et al. | Simple kinetic method for assessing catalase activity in biological samples | |
| JPS5813398A (ja) | 過酸化水素もしくは過酸化水素を形成する基質またはペルオキシダ−ゼもしくはペルオキシダ−ゼのように作用する物質を検出するための剤および方法 | |
| Martinek et al. | Simplified estimation of leucine aminopeptidase (LAP) activity | |
| MX2010011763A (es) | Prueba de acetaminofeno. | |
| JP2722874B2 (ja) | 新規Ｎ−アセチル−β−Ｄ−グルコサミン誘導体及びこれを基質に用いたＮ−アセチル−β−Ｄ−グルコサミニダーゼ活性測定法 | |
| Aoe et al. | Substrate-induced conformational changes of liver fructose 1, 6-diphosphatase studied with the hydrophobic probe, 1-anilinonaphthalene-8-sulfonate | |
| JPS61177999A (ja) | β−Ｎ−アセチル−Ｄ−ヘキソサミニダ−ゼ活性測定試薬 | |
| RU2122740C1 (ru) | Способ определения мочевины в биологических жидкостях и набор реактивов для его осуществления | |
| JPH0432835B2 (enExample) | ||
| EP0510190A1 (en) | Reagent and method for serum iron assay. | |
| JP2838866B2 (ja) | 酸化発色分析における還元物質の活性抑制方法 | |
| JPH01118768A (ja) | 発色試液の安定化方法 | |
| JPH03206896A (ja) | 体液中の微量成分定量法 | |
| US5126329A (en) | Glucosamine derivatives and compositions reagents and containing the same | |
| JPS6296099A (ja) | 酸性フオスフアタ−ゼ活性測定試薬 | |
| JPS62265298A (ja) | β−Ｎ−アセチル−Ｄ−ヘキソサミニダ−ゼ活性測定試薬 | |
| EP0411159A1 (en) | Method for determining enzymatic activity | |
| JPS6252000A (ja) | β−Ｎ−アセチル−Ｄ−ヘキソサミニダ−ゼ活性測定試薬 | |
| JPH03175997A (ja) | 総ビリルビンの定量法及びそれに用いる試薬 | |
| JPH0687798B2 (ja) | 体液中のカルシウム測定方法 | |
| JP2699147B2 (ja) | 体液中のカルシウム測定方法 | |
| AU621858B2 (en) | Calcium assay reagent | |
| Chung et al. | Comparison of two methods for determining amylase activity in serum and urine | |
| JPS6342470A (ja) | ペルオキシダ−ゼまたはｈ↓２ｏ↓２の測定方法 |